| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Jemal is Program Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Murray is Manager, Surveillance Data Systems, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Samuels is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Ghafoor is Epidemiologist, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Thun is Vice President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year, and compiles the most recent data on cancer incidence, mortality, and survival by using incidence data from the National Cancer Institute (NCI) and mortality data from the National Center for Health Statistics (NCHS). Incidence and death rates are age adjusted to the 2000 US standard population. In the year 2003, we estimate that 1,334,100 new cases of cancer will be diagnosed, and 556,500 people will die from cancer in the United States. Age-adjusted cancer death rates declined in both males and females in the 1990s, though the magnitude of decline is substantially higher in males than in females. In contrast, incidence rates continued to increase in females while stabilizing in males. African-American males showed the largest decline for mortality. However, African Americans still carry the highest burden of cancer with diagnosis of cancer at a later stage and poorer survival within each stage compared with Whites. In spite of the continued decline in cancer death rates in the most recent time period, the total number of recorded cancer deaths in the United States continues to increase slightly due to the aging and expanding population.
This article has been cited by other articles:
|
|
 |
|
  M. Tahara, K. Shirao, N. Boku, K. Yamaguchi, Y. Komatsu, Y. Inaba, T. Arai, N. Mizunuma, T. Satoh, H. Takiuchi, et al. Multicenter Phase II Study of Cetuximab Plus Irinotecan in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin and Fluoropyrimidines Jpn. J. Clin. Oncol., October 4, 2008; (2008) hyn102v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yu, W. K. K. Wu, Z. J. Li, H. P. S. Wong, E. K. K. Tai, H. T. Li, Y. C. Wu, and C. H. Cho E Series of Prostaglandin Receptor 2-Mediated Activation of Extracellular Signal-Regulated Kinase/Activator Protein-1 Signaling Is Required for the Mitogenic Action of Prostaglandin E2 in Esophageal Squamous-Cell Carcinoma J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 258 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Attard, A. H.M. Reid, T. A. Yap, F. Raynaud, M. Dowsett, S. Settatree, M. Barrett, C. Parker, V. Martins, E. Folkerd, et al. Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven J. Clin. Oncol., October 1, 2008; 26(28): 4563 - 4571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Christian, K. L. Lapane, A. L. Hume, C. B. Eaton, and M. A. Weinstock Association of ACE Inhibitors and Angiotensin Receptor Blockers with Keratinocyte Cancer Prevention in the Randomized VATTC Trial J Natl Cancer Inst, September 3, 2008; 100(17): 1223 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yogarajah, J. Soh, B. Lord, N. Goddard, and R. Stratton Palmar fasciitis and polyarthritis syndrome: a sign of ovarian malignancy J R Soc Med, September 1, 2008; 101(9): 473 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mahajan, V. Dammai, T. Hsu, and A.S. Kraft Hypoxia-inducible factor-2{alpha} regulates the expression of TRAIL receptor DR5 in renal cancer cells Carcinogenesis, September 1, 2008; 29(9): 1734 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. S. Narang, C. Fraga, N. Kumar, J. Shen, S. Throm, C. F. Stewart, and C. M. Waters Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier Am J Physiol Cell Physiol, August 1, 2008; 295(2): C440 - C450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Consedine, B. A. Adjei, P. M. Ramirez, and J. M. McKiernan An Object Lesson: Source Determines the Relations That Trait Anxiety, Prostate Cancer Worry, and Screening Fear Hold with Prostate Screening Frequency Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1631 - 1639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Parent, C. S. Dence, T. L. Sharp, M. J. Welch, and J. A. Katzenellenbogen 7{alpha}-18F-Fluoromethyl-Dihydrotestosterone and 7{alpha}-18F-Fluoromethyl-Nortestosterone: Ligands to Determine the Role of Sex Hormone-Binding Globulin for Steroidal Radiopharmaceuticals J. Nucl. Med., June 1, 2008; 49(6): 987 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Yang, K. H. Yang, Y. P. Li, Y. C. Zhang, X. D. He, A. L. Song, J. H. Tian, L. Jiang, Z. G. Bai, L. F. He, et al. Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials Ann. Onc., June 1, 2008; 19(6): 1039 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Mease, C. L. Dusich, C. A. Foss, H. T. Ravert, R. F. Dannals, J. Seidel, A. Prideaux, J. J. Fox, G. Sgouros, A. P. Kozikowski, et al. N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer Clin. Cancer Res., May 15, 2008; 14(10): 3036 - 3043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Bock, L. L. Sinclair, N. S. Bedford, R. E. Jackson, J. H. Lee, and D. K. Trask Modulation of Cellular Invasion by VEGF-C Expression in Squamous Cell Carcinoma of the Head and Neck Arch Otolaryngol Head Neck Surg, April 1, 2008; 134(4): 355 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Huang, Y. Zhang, S. Varambally, A. M. Chinnaiyan, M. Banerjee, S. D. Merajver, and C. G. Kleer Inhibition of CCN6 (Wnt-1-Induced Signaling Protein 3) Down-Regulates E-Cadherin in the Breast Epithelium through Induction of Snail and ZEB1 Am. J. Pathol., April 1, 2008; 172(4): 893 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Laquente, C. Lacasa, M. M. Ginesta, O. Casanovas, A. Figueras, M. Galan, I. G. Ribas, J. R. Germa, G. Capella, and F. Vinals Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model Mol. Cancer Ther., March 1, 2008; 7(3): 638 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Jia, S. D. Figueroa, F. Gallazzi, B. S. Balaji, M. Hannink, S. Z. Lever, T. J. Hoffman, and M. R. Lewis Molecular Imaging of bcl-2 Expression in Small Lymphocytic Lymphoma Using 111In-Labeled PNA-Peptide Conjugates J. Nucl. Med., March 1, 2008; 49(3): 430 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. de la Iglesia, G. Konopka, S. V. Puram, J. A. Chan, R. M. Bachoo, M. J. You, D. E. Levy, R. A. DePinho, and A. Bonni Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway Genes & Dev., February 15, 2008; 22(4): 449 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Pagel, N. Hedin, L. Drouet, B. L. Wood, A. Pantelias, Y. Lin, D. K. Hamlin, D. S. Wilbur, A. K. Gopal, D. Green, et al. Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy Blood, February 15, 2008; 111(4): 2261 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Wallace, J. M. S. Pascual, M. Raimondo, T. A. Woodward, B. L. McComb, J. E. Crook, M. M. Johnson, M. A. Al-Haddad, S. A. Gross, S. Pungpapong, et al. Minimally Invasive Endoscopic Staging of Suspected Lung Cancer JAMA, February 6, 2008; 299(5): 540 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Borugian, J. J. Spinelli, Z. Sun, L. N. Kolonel, I. Oakley-Girvan, M. D. Pollak, A. S. Whittemore, A. H. Wu, and R. P. Gallagher Prostate Cancer Risk in Relation to Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3: A Prospective Multiethnic Study Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 252 - 254. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zheng, J. D. Ritzenthaler, J. Roman, and S. Han Nicotine Stimulates Human Lung Cancer Cell Growth by Inducing Fibronectin Expression Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 681 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhang, K. Li, L. Wei, Z. Li, P. Yu, L. Teng, K. Wu, and J. Zhu p300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinoma J. Clin. Pathol., November 1, 2007; 60(11): 1249 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Cerfolio, A. S. Bryant, and M. A. Eloubeidi Accessing the Aortopulmonary Window (#5) and the Paraaortic (#6) Lymph Nodes in Patients With Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 2007; 84(3): 940 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Montes, L. M. Seijo, A. Campo, A. B. Alcaide, G. Bastarrika, and J. J. Zulueta Factors determining early adherence to a lung cancer screening protocol Eur. Respir. J., September 1, 2007; 30(3): 532 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Zhang, X. Tang, Z.-F. Zhang, R. Velikina, S. Shi, and A. D. Le Nicotine Induces Hypoxia-Inducible Factor-1{alpha} Expression in Human Lung Cancer Cells via Nicotinic Acetylcholine Receptor Mediated Signaling Pathways Clin. Cancer Res., August 15, 2007; 13(16): 4686 - 4694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Ferrandina, M Ludovisi, R De Vincenzo, V Salutari, D Lorusso, M Colangelo, T Prantera, M. Valerio, and G Scambia Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study Ann. Onc., August 1, 2007; 18(8): 1348 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Esposito, J. Kleeff, I. Abiatari, X. Shi, N. Giese, F. Bergmann, W. Roth, H. Friess, and P. Schirmacher Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer J. Clin. Pathol., August 1, 2007; 60(8): 885 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Lee, G. K. Lee, S.-y. Kong, M. C. Kook, S. K. Yang, S. Y. Park, S. H. Park, B. Keam, D. J. Park, B. Y. Cho, et al. Epidermal growth factor receptor status in anaplastic thyroid carcinoma J. Clin. Pathol., August 1, 2007; 60(8): 881 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jiao, S. Wang, R. Qiao, I. Vivanco, P. A. Watson, C. L. Sawyers, and H. Wu Murine Cell Lines Derived from Pten Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer Development Cancer Res., July 1, 2007; 67(13): 6083 - 6091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wu, C. Min, X. Wang, Z. Yu, K. H. Kirsch, P. C. Trackman, and G. E. Sonenshein Repression of BCL2 by the Tumor Suppressor Activity of the Lysyl Oxidase Propeptide Inhibits Transformed Phenotype of Lung and Pancreatic Cancer Cells Cancer Res., July 1, 2007; 67(13): 6278 - 6285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Heverhagen Smart Near-Infrared Imaging Probes--A Quantum Leap for Early Detection of Colorectal Cancer? Radiology, July 1, 2007; 244(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
 |
|
 P Veit-Haibach, G Antoch, T Beyer, H Stergar, R Schleucher, E A M Hauth, and A Bockisch FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy Br. J. Radiol., July 1, 2007; 80(955): 508 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Karanicolas, E. Davies, R. Kunz, M. Briel, H. P. Koka, D. M. Payne, S. E. Smith, H.-P. Hsu, P.-W. Lin, C. Bloechle, et al. The Pylorus: Take It or Leave It? Systematic Review and Meta-Analysis of Pylorus-Preserving versus Standard Whipple Pancreaticoduodenectomy for Pancreatic or Periampullary Cancer Ann. Surg. Oncol., June 1, 2007; 14(6): 1825 - 1834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Cerfolio and A. S. Bryant Surgical Techniques and Results for Partial or Circumferential Sleeve Resection of the Pulmonary Artery for Patients with Non-Small Cell Lung Cancer Ann. Thorac. Surg., June 1, 2007; 83(6): 1971 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Bock, S. G. Menon, L. L. Sinclair, N. S. Bedford, P. C. Goswami, F. E. Domann, and D. K. Trask Celecoxib Toxicity Is Cell Cycle Phase Specific Cancer Res., April 15, 2007; 67(8): 3801 - 3808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ohuchida, K. Mizumoto, J. Yu, H. Yamaguchi, H. Konomi, E. Nagai, K. Yamaguchi, M. Tsuneyoshi, and M. Tanaka S100A6 Is Increased in a Stepwise Manner during Pancreatic Carcinogenesis: Clinical Value of Expression Analysis in 98 Pancreatic Juice Samples Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 649 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Lehto Causal Attributions in Individuals With Suspected Lung Cancer: Relationships to Illness Coherence and Emotional Responses Journal of the American Psychiatric Nurses Association, April 1, 2007; 13(2): 109 - 115. [Abstract] [PDF]
|
|
|
|
 |
|
 K.-M. Chiu, S.-H. Chu, J.-S. Chen, S.-J. Li, C.-Y. Chan, and K.-S. Chen Spiral Saphenous Vein Graft for Portal Vein Reconstruction in Pancreatic Cancer Surgery Vascular and Endovascular Surgery, April 1, 2007; 41(2): 149 - 152. [Abstract] [PDF]
|
|
|
|
 |
|
 J. P. Morton, M. E. Mongeau, D. S. Klimstra, J. P. Morris, Y. C. Lee, Y. Kawaguchi, C. V. E. Wright, M. Hebrok, and B. C. Lewis Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis PNAS, March 20, 2007; 104(12): 5103 - 5108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Milenic, K. Garmestani, E. D. Brady, P. S. Albert, A. Abdulla, J. Flynn, and M. W. Brechbiel Potentiation of High-LET Radiation by Gemcitabine: Targeting HER2 with Trastuzumab to Treat Disseminated Peritoneal Disease Clin. Cancer Res., March 15, 2007; 13(6): 1926 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lahans Integrating Chinese and Conventional Medicine in Colorectal Cancer Treatment Integr Cancer Ther, March 1, 2007; 6(1): 89 - 94. [Abstract] [PDF]
|
|
|
|
 |
|
 N. S. Consedine, D. Horton, T. Ungar, A. K. Joe, P. Ramirez, and L. Borrell Fear, Knowledge, and Efficacy Beliefs Differentially Predict the Frequency of Digital Rectal Examination Versus Prostate Specific Antigen Screening in Ethnically Diverse Samples of Older Men American Journal of Men's Health, March 1, 2007; 1(1): 29 - 43. [Abstract] [PDF]
|
|
|
|
|
|
P. B. Panici, A. De Vivo, F. Bellati, N. Manci, G. Perniola, S. Basile, L. Muzii, and R. Angioli Secondary Cytoreductive Surgery in Patients with Platinum-Sensitive Recurrent Ovarian Cancer Ann. Surg. Oncol., March 1, 2007; 14(3): 1136 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kuuselo, K. Savinainen, D. O. Azorsa, G. D. Basu, R. Karhu, S. Tuzmen, S. Mousses, and A. Kallioniemi Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification Cancer Res., March 1, 2007; 67(5): 1943 - 1949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C Perez-Martinez, V. Alonso, J. L Sarasa, S.-G. Nam-Cha, R. Vela-Navarrete, F. Manzarbeitia, F. J Calahorra, and P. Esbrit Immunohistochemical analysis of low-grade and high-grade prostate carcinoma: relative changes of parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand J. Clin. Pathol., March 1, 2007; 60(3): 290 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Barbolina, B. P. Adley, E. V. Ariztia, Y. Liu, and M. S. Stack Microenvironmental Regulation of Membrane Type 1 Matrix Metalloproteinase Activity in Ovarian Carcinoma Cells via Collagen-induced EGR1 Expression J. Biol. Chem., February 16, 2007; 282(7): 4924 - 4931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Ramkissoon, P. S. Patel, M. Taborga, and P. Rameshwar Nuclear Factor-{kappa}B Is Central to the Expression of Truncated Neurokinin-1 Receptor in Breast Cancer: Implication for Breast Cancer Cell Quiescence within Bone Marrow Stroma Cancer Res., February 15, 2007; 67(4): 1653 - 1659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. K. Pulukuri, N. Estes, J. Patel, and J. S. Rao Demethylation-Linked Activation of Urokinase Plasminogen Activator Is Involved in Progression of Prostate Cancer Cancer Res., February 1, 2007; 67(3): 930 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Son, M. H. Park, S. J. Chae, S. O. Moon, J. W. Lee, H. S. Song, D. C. Moon, S. S. Kang, Y. E. Kwon, and J. T. Hong Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor {kappa}B Mol. Cancer Ther., February 1, 2007; 6(2): 675 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Souglakos, A Kalykaki, L Vamvakas, N Androulakis, K Kalbakis, S Agelaki, N Vardakis, M Tzardi, A. Kotsakis, J Gioulbasanis, et al. Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy Ann. Onc., February 1, 2007; 18(2): 305 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A Silvestri, P. J Nietert, J. Zoller, C. Carter, and D. Bradford Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts Thorax, February 1, 2007; 62(2): 126 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gridelli, P. Maione, F. Del Gaizo, G. Colantuoni, C. Guerriero, C. Ferrara, D. Nicolella, D. Comunale, A. De Vita, and A. Rossi Sorafenib and Sunitinib in the Treatment of Advanced Non-Small Cell Lung Cancer Oncologist, February 1, 2007; 12(2): 191 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. de Bono, J. Bellmunt, G. Attard, J. P. Droz, K. Miller, A. Flechon, C. Sternberg, C. Parker, G. Zugmaier, V. Hersberger-Gimenez, et al. Open-Label Phase II Study Evaluating the Efficacy and Safety of Two Doses of Pertuzumab in Castrate Chemotherapy-Naive Patients With Hormone-Refractory Prostate Cancer J. Clin. Oncol., January 20, 2007; 25(3): 257 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Arumugam, V. Ramachandran, and C. D. Logsdon Effect of Cromolyn on S100P Interactions With RAGE and Pancreatic Cancer Growth and Invasion in Mouse Models J Natl Cancer Inst, December 20, 2006; 98(24): 1806 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Davis, K. J. Wojno, S. Daignault, M. D. Hofer, R. Kuefer, M. A. Rubin, and M. L. Day Elevated E2F1 Inhibits Transcription of the Androgen Receptor in Metastatic Hormone-Resistant Prostate Cancer Cancer Res., December 15, 2006; 66(24): 11897 - 11906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lanuti, P. E. de Delva, A. Maher, C. D. Wright, H. A. Gaissert, J. C. Wain, D. M. Donahue, and D. J. Mathisen Feasibility and Outcomes of an Early Extubation Policy After Esophagectomy Ann. Thorac. Surg., December 1, 2006; 82(6): 2037 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Grubbs, Z. Abdel-Wahab, D. S. Tyler, and S. K. Pruitt Utilizing Quantitative Polymerase Chain Reaction to Evaluate Prostate Stem Cell Antigen as a Tumor Marker in Pancreatic Cancer Ann. Surg. Oncol., December 1, 2006; 13(12): 1645 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Cerfolio, A. S. Bryant, E. Scott, M. Sharma, F. Robert, S. A. Spencer, and R. I. Garver Women With Pathologic Stage I, II, and III Non-small Cell Lung Cancer Have Better Survival Than Men Chest, December 1, 2006; 130(6): 1796 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
